YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer

NCT07390565 · clinicaltrials.gov ↗

NA

Phase

ENROLLING_BY_INVITATION

Status

308

Enrollment

OTHER

Sponsor class

Conditions

Extensive-stage Small Cell Lung Cancer (SCLC)

Interventions

DRUG: Yishen Qutong Granules
DRUG: Yishen Qutong Simulant Granules

Sponsor

LI FENG

Collaborators

[object Object]
[object Object]
[object Object]